Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: K3 director linked to purchase, Diurnal exec sells shares into ISA

(Sharecast News) - Software company K3 Business Technology was at the top of the list of buys on Monday, after Kestrel Partners spent more than £40k on its shares. The AIM-traded firm said Kestrel Partners, on behalf of its discretionary clients, bought 27,129 shares for 150p each, spending a total of £40,693.50.

Its non-executive director Oliver Scott is a partner of, and holds a beneficial interest in Kestrel, and is also a shareholder in one of Kestrel's clients, Kestrel Opportunities, and so has a beneficial interest in Kestrel Opportunities' entire legal holding in the company.

Following the purchase, K3 said Kestrel Opportunities held 8,515,879 of its shares, and other clients of Kestrel in which Scott had no beneficial interest held 2,775,101 shares.

In total, Kestrel indirectly held voting rights over 11,290,980 of K3's shares, representing 25.24% percent of its issued share capital.

On the selling side of the ledger, specialty pharmaceutical company Diurnal Group disclosed a sale worth over £40k made by its chief scientific officer.

The AIM-traded firm said Richard Ross sold 312,000 shares for 13p each, while his and his wife's individual savings accounts (ISAs) purchased 153,500 and 153,500 shares, respectively, at a price of 13.01p each.

Following the transactions, the total beneficial interest of Richard Ross and his connected parties was 2,257,155 shares, representing 1.33% of Diurnal's total voting rights as of 9 May.

Top Director Buys

K3 Business Technology Group (KBT) Director name: Scott,Oliver Rupert Andrew Amount purchased: 27,129 @ 150.00p Value: £40,693.50

Diurnal Group (DNL) Director name: Ross,Richard Amount purchased: 153,500 @ 13.01p Value: £19,970.35

Diurnal Group (DNL) Director name: Ross,Richard Amount purchased: 153,500 @ 13.01p Value: £19,970.35

Discoverie Group (DSCV) Director name: Watson ,Clive Amount purchased: 2,875 @ 690.00p Value: £19,837.50

Henderson Smaller Companies Inv Trust (HSL) Director name: Carter,Kevin Amount purchased: 1,500 @ 868.36p Value: £13,025.39

Target Healthcare Reit Ltd (THRL) Director name: Fyfe,Alison Amount purchased: 10,000 @ 109.80p Value: £10,980.00

Mgc Pharmaceuticals Limited Npv (di) (MXC) Director name: Zomer,Roby Amount purchased: 819,672 @ 1.30p Value: £10,655.74

Parity Group (PTY) Director name: Johns,Mike Amount purchased: 139,082 @ 7.19p Value: £10,000.00

Mondi (MNDI) Director name: Strank,Angela Amount purchased: 628 @ 1,579.95p Value: £9,922.08

Henderson Smaller Companies Inv Trust (HSL) Director name: Freer,Penelope Anne Amount purchased: 1,000 @ 878.92p Value: £8,789.20

Reach (RCH) Director name: Panayi,Barry Amount purchased: 3,979 @ 124.72p Value: £4,962.77

Capita (CPI) Director name: Murphy,Joseph Amount purchased: 643 @ 26.83p Value: £172.52

Capita (CPI) Director name: Lewis,Jonathan (Jon) Amount purchased: 643 @ 26.83p Value: £172.52

Capita (CPI) Director name: Weller,Tim Amount purchased: 643 @ 26.83p Value: £172.52

Assura (AGR) Director name: Cottam,Jayne Amount purchased: 228 @ 66.16p Value: £150.84

Assura (AGR) Director name: Murphy,Jonathan Amount purchased: 228 @ 66.16p Value: £150.84

Top Director Sells

Rolls-royce Holdings (RR.) Director name: East,Warren Amount sold: 210,515 @ 83.78p Value: £176,369.47

Diurnal Group (DNL) Director name: Ross,Richard Amount sold: 312,000 @ 13.00p Value: £40,560.00

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.